Search Results

Tirapazamine 1000mg 1000mg  | Purity Not Available

Adooq Bioscience

Tirapazamine is a bioreductive, anti-neoplastic, anti-cancer agent that is selectively toxic to cells under hypoxic conditions.

More Information Supplier Page

Tirapazamine 100mg 100mg  | Purity Not Available

Adooq Bioscience

Tirapazamine is a bioreductive, anti-neoplastic, anti-cancer agent that is selectively toxic to cells under hypoxic conditions.

More Information Supplier Page

RC-3095 50mg 50mg  | Purity Not Available

Adooq Bioscience

RC-3095 is a bombesin/gastrin-releasing peptide (BN/GRP) antagonist with potential anticancer activity.

More Information Supplier Page

RC-3095 5mg 5mg  | Purity Not Available

Adooq Bioscience

RC-3095 is a bombesin/gastrin-releasing peptide (BN/GRP) antagonist with potential anticancer activity.

More Information Supplier Page

RC-3095 25mg 25mg  | Purity Not Available

Adooq Bioscience

RC-3095 is a bombesin/gastrin-releasing peptide (BN/GRP) antagonist with potential anticancer activity.

More Information Supplier Page

RC-3095 10mg 10mg  | Purity Not Available

Adooq Bioscience

RC-3095 is a bombesin/gastrin-releasing peptide (BN/GRP) antagonist with potential anticancer activity.

More Information Supplier Page

NU7026 50mg 50mg  | Purity Not Available

Adooq Bioscience

NU7026 is a novel DNA-dependent protein kinase inhibitor that potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia.

More Information Supplier Page

NU7026 25mg 25mg  | Purity Not Available

Adooq Bioscience

NU7026 is a novel DNA-dependent protein kinase inhibitor that potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia.

More Information Supplier Page

Tirapazamine 500mg 500mg  | Purity Not Available

Adooq Bioscience

Tirapazamine is a bioreductive, anti-neoplastic, anti-cancer agent that is selectively toxic to cells under hypoxic conditions.

More Information Supplier Page